{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:30:59Z","timestamp":1794490259504,"version":"4.9.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Reviews"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.trre.2026.101051","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:26:09Z","timestamp":1787034369000},"page":"101051","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Joint British Transplantation Society and British Cardiovascular Society guidelines on non-ischaemic cardiac disease in patients being considered for kidney transplantation"],"prefix":"10.1016","volume":"40","author":[{"given":"LauraAnn","family":"McGill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Corr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Ferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Fossati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Graham-Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Howse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paramjit","family":"Jeetley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Kojro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirini","family":"Lioudaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"Madden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramod","family":"Nagaraja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6044-5827","authenticated-orcid":false,"given":"Ailish","family":"Nimmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Sharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imeshi","family":"Wijetunga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Ludman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellie","family":"Asgari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trre.2026.101051_bb0010","author":"BTS"},{"key":"10.1016\/j.trre.2026.101051_bb0015","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.trre.2026.101051_bb0005","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1002\/ehf2.14447","article-title":"Heart failure with preserved ejection fraction in haemodialysis patients: prevalence, diagnosis, risk factors, prognosis","volume":"10","author":"Yu","year":"2023","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.trre.2026.101051_bb0020","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1186\/s12882-020-02074-3","article-title":"Left-sided heart disease and risk of death in patients with end-stage kidney disease receiving haemodialysis: an observational study","volume":"21","author":"Axelsson Raja","year":"2020","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.trre.2026.101051_bb0025","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/ki.1995.132","article-title":"Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors","volume":"47","author":"Harnett","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2026.101051_bb0030","doi-asserted-by":"crossref","first-page":"380","DOI":"10.5414\/CNP71380","article-title":"NT-pro-BNP is an independent predictor of mortality in patients with end-stage renal disease","volume":"71","author":"Svensson","year":"2009","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.trre.2026.101051_bb0035","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1097\/01.tp.0000295748.42884.97","article-title":"The impact of left ventricular systolic dysfunction on survival after renal transplantation","volume":"84","author":"Siedlecki","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2026.101051_bb0040","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/TP.0000000000003136","article-title":"KDIGO clinical practice guideline on the evaluation and management of candidates for kidney transplantation","volume":"104","author":"Chadban","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2026.101051_bb0045","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.1161\/CIR.0000000000001285","article-title":"AHA\/ACC\/ACS\/ASNC\/HRS\/SCA\/SCCT\/SCMR\/SVM guideline for perioperative cardiovascular management for noncardiac surgery: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"150","author":"Thompson","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.trre.2026.101051_bb0050","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1093\/eurheartj\/ehac270","volume":"43","author":"ESC Scientific Document Group","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.trre.2026.101051_bb0055","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.amjcard.2016.10.021","article-title":"Referral for specialist follow-up and its association with post-discharge mortality among patients with systolic heart failure (from the National Heart Failure Audit for England and Wales)","volume":"119","author":"Emdin","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.trre.2026.101051_bb0060","article-title":"Heart failure specialist care and long-term outcomes for patients admitted with acute heart failure","author":"Cannata","year":"2024","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.trre.2026.101051_bb0065","doi-asserted-by":"crossref","first-page":"834","DOI":"10.5152\/AnatolJCardiol.2021.68295","article-title":"Improvement in cardiac function after renal transplantation in four patients with severe left ventricular systolic dysfunction","volume":"25","author":"Aslanger","year":"2021","journal-title":"Anatol J Cardiol"},{"key":"10.1016\/j.trre.2026.101051_bb0070","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/j.jacc.2015.08.022","article-title":"Reverse left ventricular remodeling after kidney transplantation: unraveling the complex autointoxication of uremia","volume":"66","author":"Katz","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.trre.2026.101051_bb0075","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.4103\/1319-2442.301170","article-title":"The effect of renal transplantation on cardiac functions","volume":"31","author":"Yilmaz","year":"2020","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1016\/j.trre.2026.101051_bb0080","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0735-1097(00)01158-X","article-title":"Dilated cardiomyopathy in dialysis patients\u2014beneficial effects of carvedilol: a double-blind, placebo-controlled trial","volume":"37","author":"Cice","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.trre.2026.101051_bb0085","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002584","article-title":"Prognostic benefits of carvedilol, bisoprolol, and metoprolol controlled release\/extended release in hemodialysis patients with heart failure: a 10-year cohort","volume":"5","author":"Tang","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.trre.2026.101051_bb0090","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1053\/j.ajkd.2018.02.350","article-title":"A comparative study of carvedilol versus metoprolol initiation and 1-year mortality among individuals receiving maintenance hemodialysis","volume":"72","author":"Assimon","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trre.2026.101051_bb0095","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.jacc.2010.03.105","article-title":"Effects of telmisartan added to angiotensin-converting enzyme inhibitors on mortality and morbidity in hemodialysis patients with chronic heart failure: a double-blind, placebo-controlled trial","volume":"56","author":"Cice","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.trre.2026.101051_bb0100","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/eurjhf\/hft082","article-title":"Renin\u2013angiotensin system blockade in heart failure patients on long-term haemodialysis in Taiwan","volume":"15","author":"Tang","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.trre.2026.101051_bb0105","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ahj.2007.03.017","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease","volume":"153","author":"Berger","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.trre.2026.101051_bb0110","first-page":"2257","article-title":"Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor\/angiotensin receptor blocker withdrawal in advanced renal disease (STOP-ACEi)","volume":"387","author":"STOP-ACEi Trial Investigators","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2026.101051_bb0115","first-page":"288","article-title":"Use of angiotensin receptor neprilysin inhibitor in patients on maintenance hemodialysis with reduced cardiac ejection fraction, real-world experience from a single center","volume":"15","author":"Lihua","year":"2021","journal-title":"Iran J Kidney Dis"},{"key":"10.1016\/j.trre.2026.101051_bb0120","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.026407","article-title":"Sacubitril\/valsartan in patients with heart failure and concomitant end-stage kidney disease","volume":"11","author":"Niu","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.trre.2026.101051_bb0125","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.jchf.2024.03.014","article-title":"Sacubitril\/Valsartan in Patients with Heart Failure and Deterioration in eGFR to <30 ml\/min\/1.73 m2","volume":"12","author":"Chatur","year":"2024","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.trre.2026.101051_bb0130","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1016\/j.jacc.2024.03.392","article-title":"Effects of sacubitril\/valsartan across the spectrum of renal impairment in patients with heart failure","volume":"83","author":"Chatur","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.trre.2026.101051_bb0135","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000545195","article-title":"Sacubitril-valsartan lowers blood pressure in patients on dialysis: a randomized controlled multicenter study","volume":"11","author":"Lin","year":"2025","journal-title":"Kidney Dis"},{"key":"10.1016\/j.trre.2026.101051_bb0140","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.kint.2018.08.034","article-title":"Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trial","volume":"95","author":"Charytan","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2026.101051_bb0145","first-page":"392","article-title":"Spironolactone in chronic hemodialysis patients improves cardiac function","volume":"20","author":"Taheri","year":"2009","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1016\/j.trre.2026.101051_bb0150","first-page":"507","article-title":"A prospective double-blind randomized placebo-controlled clinical trial to evaluate the safety and efficacy of spironolactone in patients with advanced congestive heart failure on continuous ambulatory peritoneal dialysis","volume":"23","author":"Taheri","year":"2012","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1016\/j.trre.2026.101051_bb0155","first-page":"705","article-title":"Spironolactone in patients on chronic haemodialysis at high risk for cardiovascular disease (ALCHEMIST): a multicentre, randomised, double-blind, placebo-controlled, event-driven trial","volume":"405","author":"Walsh","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.trre.2026.101051_bb0160","first-page":"718","article-title":"Spironolactone versus placebo in patients undergoing maintenance dialysis (ACHIEVE): an international, randomised, double-blind, placebo-controlled trial","volume":"405","author":"Walsh","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.trre.2026.101051_bb0165","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2026.101051_bb0170","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2026.101051_bb0175","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2026.101051_bb0180","first-page":"e2360","article-title":"SGLT2 inhibitors in stage 5 chronic kidney disease: an emulated target trial using nationwide data","volume":"109","author":"Chang","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.trre.2026.101051_bb0185","first-page":"6409","article-title":"SGLT2 inhibitors in diabetes with advanced chronic kidney disease: a nationwide cohort study","volume":"13","author":"Peng","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.trre.2026.101051_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ndt\/gfaf046","article-title":"Rationale and design of the renal lifecycle trial assessing the effect of dapagliflozin on cardiorenal outcomes in severe chronic kidney disease","volume":"40","author":"Bakker","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trre.2026.101051_bb0195","doi-asserted-by":"crossref","DOI":"10.15420\/ecr.2021.25","article-title":"Valvular heart disease in patients with chronic kidney disease","volume":"17","author":"Kipourou","year":"2022","journal-title":"Eur Cardiol Rev"},{"key":"10.1016\/j.trre.2026.101051_bb0200","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12872-018-0747-y","article-title":"Cardiac valve calcification and risk of cardiovascular or all-cause mortality in dialysis patients: a meta-analysis","volume":"18","author":"Wang","year":"2018","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.trre.2026.101051_bb0205","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1161\/ATVBAHA.114.302523","article-title":"Calcific aortic valve disease","volume":"34","author":"Yutzey","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trre.2026.101051_bb0210","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.atherosclerosis.2015.07.013","article-title":"Prevalence and correlates of mitral annular calcification in adults with chronic kidney disease: results from CRIC study","volume":"242","author":"Abd alamir","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.trre.2026.101051_bb0215","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12574-019-00436-x","article-title":"Echocardiographic assessment of cardiac structure and function in chronic renal disease","volume":"17","author":"Dohi","year":"2019","journal-title":"J Echocardiogr"},{"key":"10.1016\/j.trre.2026.101051_bb0220","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006044","article-title":"Prevalence and outcomes of left-sided Valvular heart disease associated with chronic kidney disease","volume":"6","author":"Samad","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.trre.2026.101051_bb0225","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.kint.2019.06.025","article-title":"Chronic kidney disease and valvular heart disease: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference","volume":"96","author":"Marwick","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2026.101051_bb0230","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.trre.2026.101051_bb0235","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/MOT.0000000000000942","article-title":"Cardiovascular risk stratification in the noncardiac solid organ transplant candidate","volume":"27","author":"Truby","year":"2022","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.trre.2026.101051_bb0240","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.118.007552","article-title":"Outcomes after transcatheter mitral valve repair in patients with renal disease","volume":"12","author":"Shah","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.trre.2026.101051_bb0245","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1161\/CIRCULATIONAHA.109.192230","article-title":"ACCF\/AHA 2009 expert consensus document on pulmonary hypertension","volume":"119","author":"McLaughlin","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.trre.2026.101051_bb0250","first-page":"363","article-title":"World Health Organization Group I pulmonary hypertension","volume":"34","author":"Prins","year":"2016","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.trre.2026.101051_bb0255","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1681\/ASN.2014111111","article-title":"Prevalence, predictors, and outcomes of pulmonary hypertension in CKD","volume":"27","author":"Navaneethan","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2026.101051_bb0260","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12882-018-0866-9","article-title":"Epidemiology and risk factors in CKD patients with pulmonary hypertension: a retrospective study","volume":"19","author":"Zhang","year":"2018","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.trre.2026.101051_bb0265","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1053\/j.ajkd.2019.08.027","article-title":"Pulmonary hypertension subtypes and mortality in CKD","volume":"75","author":"Edmonston","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trre.2026.101051_bb0270","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/s41581-024-00857-7","article-title":"Pulmonary hypertension and chronic kidney disease: prevalence, pathophysiology and outcomes","volume":"20","author":"Zeder","year":"2024","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.trre.2026.101051_bb0275","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1053\/j.ajkd.2019.12.005","article-title":"Diagnosis and management of pulmonary hypertension in patients with CKD","volume":"75","author":"Walther","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trre.2026.101051_bb0280","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/TP.0000000000001043","article-title":"Evaluation and management of pulmonary hypertension in kidney transplant candidates and recipients","volume":"101","author":"Lentine","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2026.101051_bb0285","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1177\/2045893217716108","article-title":"Pulmonary hypertension in patients with chronic kidney disease: invasive hemodynamic etiology and outcomes","volume":"7","author":"O\u2019Leary","year":"2017","journal-title":"Pulm Circ"},{"key":"10.1016\/j.trre.2026.101051_bb0290","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.029024","article-title":"Revised definition of pulmonary hypertension and approach to management: a clinical primer","volume":"12","author":"Maron","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.trre.2026.101051_bb0295","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J"}],"container-title":["Transplantation Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X26000613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X26000613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T12:45:00Z","timestamp":1794487500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955470X26000613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S0955470X26000613"],"URL":"https:\/\/doi.org\/10.1016\/j.trre.2026.101051","relation":{},"ISSN":["0955-470X"],"issn-type":[{"value":"0955-470X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Joint British Transplantation Society and British Cardiovascular Society guidelines on non-ischaemic cardiac disease in patients being considered for kidney transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trre.2026.101051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101051"}}